Thornburg Investment Management Inc Dexcom Inc Transaction History

Thornburg Investment Management Inc

$6.78 Billion
Q2 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$84.79 - $104.74 $54,943 - $67,871	-648 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$78.0 - $104.5 $1.84 Million - $2.46 Million	-23,547 Reduced 97.32%	648 $240,000
Q3 2020 Nov 05, 2020	BUY	$95.51 - $112.95 $44,698 - $52,860	468 Added 1.97%	24,195 $9.97 Million
Q2 2020 Aug 07, 2020	SELL	$62.68 - $105.34 $2,381 - $4,002	-38 Reduced 0.16%	23,727 $9.62 Million
Q1 2020 May 13, 2020	SELL	$47.79 - $75.63 $285,545 - $451,889	-5,975 Reduced 20.09%	23,765 $6.4 Million
Q4 2019 Feb 10, 2020	SELL	$36.62 - $57.29 $1.78 Million - $2.79 Million	-48,674 Reduced 62.07%	29,740 $6.51 Million
Q3 2019 Nov 12, 2019	SELL	$35.53 - $43.8 $4,938 - $6,088	-139 Reduced 0.18%	78,414 $11.7 Million
Q1 2019 May 07, 2019	SELL	$28.07 - $38.18 $422,425 - $574,570	-15,049 Reduced 16.08%	78,553 $9.36 Million
Q4 2018 Feb 06, 2019	SELL	$26.99 - $37.37 $306,390 - $424,224	-11,352 Reduced 10.82%	93,602 $11.2 Million
Q3 2018 Nov 02, 2018	SELL	$23.35 - $36.72 $1.84 Million - $2.9 Million	-78,967 Reduced 42.94%	104,954 $15 Million
Q2 2018 Aug 14, 2018	SELL	$17.54 - $25.22 $170,015 - $244,457	-9,693 Reduced 5.01%	183,921 $17.5 Million
Q1 2018 May 07, 2018	SELL	$13.06 - $18.54 $1.34 Million - $1.9 Million	-102,304 Reduced 34.57%	193,614 $14.4 Million
Q4 2017 Feb 14, 2018	BUY	$11.12 - $15.38 $400,998 - $554,618	36,061 Added 13.88%	295,918 $17 Million
Q3 2017 Nov 13, 2017	BUY	$11.36 - $18.98 $845,331 - $1.41 Million	74,413 Added 40.13%	259,857 $12.7 Million
Q2 2017 Aug 14, 2017	BUY	N/A	185,444	185,444 $13.6 Million

Others Institutions Holding DXCM

# of Institutions

1,112

Shares Held

365M

Call Options Held

4.1M

Put Options Held

3.65M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $26B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thornburg Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Thornburg Investment Management Inc with notifications on news.

Account